Figure 10.

The effects of the EGCG nano-liposome formulation on TGF-β signalling. After 24 h of seeding the HEK293T cells in a 96-well half-area plate, cells were then transfected with TGFBRII, SBE-Luc, and βgal. After 24 h, these were treated with the compounds EGCG (free EGCG) and L(EGCG) (EGCG nano-liposomes at various concentrations), and L (liposomes without EGCG). These treatments were compared with the untreated TGFBRII, SBE-Luc, and βgal, which was set as 100. One-way ANOVA and Tukey’s post-hoc test were used. An unpaired parametric t-test was used for statistical analysis, where the APA style p-values were used: 0.12 (ns), 0.033 (*), and <0.001 (***).